{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:00:50Z","timestamp":1773154850561,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T00:00:00Z","timestamp":1313971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023720","type":"journal-article","created":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T17:20:23Z","timestamp":1314206423000},"page":"e23720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK\/ERK\/JNK and JAK2\/STAT3 \/AKT Signalings"],"prefix":"10.1371","volume":"6","author":[{"given":"Jian feng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang sen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen yong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong wen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Kai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan jie","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,8,22]]},"reference":[{"issue":"1","key":"ref1","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.","volume":"Res.56","author":"E Buchdunger","year":"1996","journal-title":"Cancer"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.","volume":"Med.348","author":"SG O'Brien","year":"2003","journal-title":"N Engl J"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.","volume":"349","author":"TP Hughes","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","article-title":"Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.","volume":"99","author":"M Talpaz","year":"2002","journal-title":"Blood"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.","volume":"99","author":"CL Sawyers","year":"2002","journal-title":"Blood"},{"issue":"23","key":"ref6","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.","volume":"355","author":"BJ Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis.","volume":"103","author":"B Calabretta","year":"2004","journal-title":"Blood"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.leu.2402577","article-title":"Chronic myelogenous leukemia: mechanisms underlying disease progression.","volume":"16","author":"AS Shet","year":"2002","journal-title":"Leukemia"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.","volume":"7","author":"E Weisberg","year":"2005","journal-title":"Cancer Cell"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2004.10.002","article-title":"Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells.","volume":"504","author":"ZQ Wang","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref11","first-page":"1509","article-title":"Protective effect of Icariin on primary cultured neonatal rat cardiomyocytes treated with isoproterenol-induced injury.","author":"H Liu","year":"2006","journal-title":"Chin pharmacol Bull(12)"},{"issue":"8","key":"ref12","first-page":"910","article-title":"Immunoregulatory effects of the herba Epimediia glycoside icariin.","volume":"45","author":"W He","year":"1995","journal-title":"Arzneimittelforschung"},{"issue":"11","key":"ref13","first-page":"1","article-title":"Experimental study on Icariin induced apoptosis of cultured liver cancer cell smmc-7721.","volume":"7","author":"ZH Zhang","year":"2006","journal-title":"Practical clinical medicine"},{"issue":"10","key":"ref14","first-page":"1213","article-title":"Icariin reverses malignant phenotype of gastric carcinoma cells.","volume":"23","author":"JW Zhang","year":"2006","journal-title":"Chin Experiment Surgical Journal"},{"key":"ref15","first-page":"53","article-title":"Effects of icariin on the differentiation of HL-60 cells.","volume":"19","author":"Z Yi","year":"1997","journal-title":"Zhong hua zhong liu za zhi"},{"issue":"6","key":"ref16","first-page":"322","article-title":"Effects of icariin on apoptosis inducement and oncogene expression for HL-60 cells.","volume":"2002; 23","author":"GX Li","year":"2002","journal-title":"Chin J Hematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1182\/blood-2003-01-0083","article-title":"Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro.","volume":"102","author":"PT Ferrao","year":"2003","journal-title":"Blood"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0145-2126(99)00198-8","article-title":"Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells.","volume":"24","author":"CQ Zhang GS Tu","year":"2000","journal-title":"Leuk Res"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00277-007-0385-4","article-title":"Dup-697, a specific COX-2 inhibitor, suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation.","volume":"87","author":"HL Peng","year":"2008","journal-title":"Ann Hematol"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1096\/fasebj.12.7.531","article-title":"Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin.","volume":"12","author":"N Belhac\u00e8ne","year":"1998","journal-title":"FASEB J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.1998.00823.x","article-title":"Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukemia patients using real-time quantitative RT-PCR.","volume":"102","author":"E Mensink","year":"1998","journal-title":"Br J Haematol"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.2910240603","article-title":"Glycophorin A as a cell surface marker of early erythroid differentiation in acute leukemia.","volume":"24","author":"LC Andersson","year":"1979","journal-title":"Int J Cancer"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1073\/pnas.0307075101","article-title":"Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.","volume":"101","author":"S Uddin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/scd.2007.0206","article-title":"Involvement of p38MAPK and reactive oxygen species in icariin-induced cardiomyocyte differentiation of murine embryonic stem cells in vitro.","volume":"17","author":"L Ding","year":"2008","journal-title":"Stem Cells Dev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1204834","article-title":"Involvement of Jak-2 tyrosine phosphorylation in Bcr-Abl transformation.","volume":"20","author":"S Xie","year":"2001","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","article-title":"Janus Kinase 2: a critical target in chronic myelogenous leukemia.","volume":"66","author":"AK Samanta","year":"2006","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1079-9796(03)00070-6","article-title":"Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells.","volume":"31","author":"K Kawauchi","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1038\/sj.onc.1206607","article-title":"Constitutive and specific activation of STAT3 by BCR\/ABL in embryonic stem cells.","volume":"22","author":"P Coppo","year":"2003","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis.","volume":"326","author":"GM Cohen","year":"1997","journal-title":"Biochem J"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.cdd.4400598","article-title":"Caspase structure, proteolytic substrates, and function during apoptotic cell death.","volume":"6","author":"DW Nicholson","year":"1999","journal-title":"Cell Death Differ"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy.","volume":"108","author":"RW Johnstone","year":"2002","journal-title":"Cell"},{"issue":"55","key":"ref32","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1038\/sj.onc.1204038","article-title":"Mouse models in the study of the Ets family of transcription factors.","volume":"19","author":"FO Bartel","year":"2000","journal-title":"Oncogene"},{"issue":"21","key":"ref33","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/sj.onc.1205318","article-title":"Hematopoietic cytokines, transcription factors and lineage commitment.","volume":"21","author":"J Zhu","year":"2002","journal-title":"Oncogene"},{"issue":"9","key":"ref34","first-page":"481","article-title":"Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells.","volume":"12","author":"JI Park","year":"2001","journal-title":"Cell Growth Differ"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/dbio.1999.9596","article-title":"Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes.","volume":"218","author":"SM Davidson","year":"2000","journal-title":"Dev Biol"},{"issue":"5","key":"ref36","first-page":"1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.","volume":"83","author":"A McGahon","year":"1994","journal-title":"Blood"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0145-2126(01)00197-7","article-title":"Bcr-Abl variants: biological and clinical aspects.","volume":"26","author":"AS Advani","year":"2002","journal-title":"Leuk Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.","volume":"247","author":"TG Lugo","year":"1990","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia.","volume":"96","author":"MW Deininger","year":"2000","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.leu.2402577","article-title":"Chronic myelogenous leukemia: mechanisms underlying disease progression.","volume":"16","author":"AS Shet","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.","volume":"13","author":"L Puil","year":"1994","journal-title":"EMBO J"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V92.7.2450","article-title":"Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.","volume":"92","author":"GS Burgess","year":"1998","journal-title":"Blood"},{"issue":"1","key":"ref43","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells.","volume":"62","author":"C Yu","year":"2002","journal-title":"Cancer Res"},{"key":"ref44","first-page":"945","article-title":"Activated STAT signaling in human tumors provides novel molecular targets for therapeutic invention.","volume":"8","author":"R Buettner","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0301-472X(01)00787-1","article-title":"Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.","volume":"30","author":"K Spiekermann","year":"2002","journal-title":"Exp Hematol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"The transformation of hematorpoietic cells by Bcr\/Abl, requires activation of a PI-3k\/Akt-dependent pathway.","volume":"16","author":"T Skorski","year":"1997","journal-title":"EMBO J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T16:11:51Z","timestamp":1592842311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023720"}},"subtitle":[],"editor":[{"given":"Kevin D.","family":"Bunting","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,22]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023720","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,22]]}}}